Don Healey's Net Worth
$612 Thousand
Who is Don Healey?
Don Healey does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., and Opexa Therapeutics, Inc..
SEC CIK
Don Healey's CIK is 0001643067
Past Insider Trading and Trends
2023 was Don Healey's most active year for acquiring shares with 7 total transactions. Don Healey's most active month to acquire stocks was the month of December. 2023 was Don Healey's most active year for disposing of shares, totalling 7 transactions. Don Healey's most active month to dispose stocks was the month of July. 2024 saw Don Healey paying a total of $0.00 for 502,928 shares, this is the most they've acquired in one year. In 2022 Don Healey cashed out on 24,532 shares for a total of $357,421.19, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adicet Bio, Inc. (ACET) Snapshot price: $1.56
Chief Technology OfficerDon Healey owns 72,329 units of Common Stock which is worth $112,833.24. In the year 2024 Don Healey filed a total of 17 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +25.79% | 14.83K |
$2.40 | -$11,688.00 | 72.33K |
Jan 24
| |||
Form 4
| -13.62% | -9.07K |
$1.37 | -$12,424.53 | 57.5K |
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
| -6.38% | -4.53K |
$7.57 | -$34,326.60 | 66.57K |
Scheduled
|
Feb 15
| ||
Form 4
| -12.83% | -10.47K |
$7.98 | -$83,476.42 | 71.1K |
Scheduled
|
Feb 10
| ||
Form 4
| +47.05% | 26.1K |
—
|
—
| 81.57K |
Jan 24
| |||
Form 4
| -12.51% | -7.93K |
$14.22 | -$112,807.26 | 55.47K |
Oct 4
| |||
Form 4
| +19.77% | 10.47K |
$18.25 | -$100,977.25 | 63.4K |
Aug 4
| |||
Form 4
| +24.65% | 10.47K |
$14.27 | -$78,955.91 | 52.93K |
Feb 14
| |||
Form 4
| +32.71% | 10.47K |
$11.69 | -$64,680.77 | 42.47K |
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
∞
| 80K |
—
|
—
| 80K |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Opexa Therapeutics, Inc. (ACER) Snapshot price: $0.8675
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||